EMAIL THIS PAGE TO A FRIEND

Clinical Cancer Research

Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2-SN-38 Antibody Conjugate (Sacituzumab Govitecan).


PMID 26106073

Abstract

We're sorry this abstract is currently not available.